Efficacy and safety of transarterial therapy combined with donafenib plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter retrospective study.

被引:0
作者
Shang, Changzhen
Zhong, Jinyi
Luo, Xuan
Zhang, Bo
Chen, Huanwei
Wang, Fengjie
Jiang, Xiaofeng
Cao, Liangqi
Shen, Shun-Li
Chen, Yajin
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China
[2] Hexian Hosp Panyu Dist, Dept Minimally Invas Intervent Radiol, Guangzhou, Peoples R China
[3] First Peoples Hosp Foshan, Dept Hepatobiliary Surg, Foshan, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Hepatopancreatobiliary Surg, Guangzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16133
引用
收藏
页数:1
相关论文
empty
未找到相关数据